Cargando…
Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients
The neurotransmitter noradrenaline (NA) mediates arousal, attention and mood, and exerts anti-inflammatory and neuroprotective effects. Alterations of monoamine signalling were reported in multiple sclerosis (MS) and psychiatric illness and may account for the high prevalence of comorbid depression...
Autores principales: | Schmidt, Elisa, Schinke, Christian, Rullmann, Michael, Luthardt, Julia, Becker, Georg-Alexander, Haars, Sarah, Stoppe, Muriel, Lobsien, Donald, Hoffmann, Karl-Titus, Sabri, Osama, Hesse, Swen, Then Bergh, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474089/ https://www.ncbi.nlm.nih.gov/pubmed/32887904 http://dx.doi.org/10.1038/s41598-020-70732-5 |
Ejemplares similares
-
HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
por: Schinke, Christian, et al.
Publicado: (2022) -
Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity
por: Griebsch, Nora-Isabell, et al.
Publicado: (2022) -
Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
por: Grundmann, Rico, et al.
Publicado: (2020) -
Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[(11)C]methylreboxetine positron emission tomography study
por: Ulke, Christine, et al.
Publicado: (2019) -
Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity
por: Schweickert de Palma, Eva, et al.
Publicado: (2022)